Ticker League

Operating Cash Flow for Bio-Techne (TECH)

As of · Reported

Metric

Latest period

$86.66M

YoY change

-3.8%

5Y CAGR

+7.0%

Peak year (2021)

$352.16M

Operating Cash Flow history chart for Bio-Techne (TECH) from 1990 to 2025

Latest: $287.56M

Operating Cash Flow growth chart for Bio-Techne (TECH) from 1990 to 2025

Latest: -3.8%

Operating Cash Flow history table for Bio-Techne (TECH) from 1990 to 2025

  • 2025$287.56M-3.8%
  • 2024$298.98M+17.5%
  • 2023$254.39M-21.8%
  • 2022$325.27M-7.6%
  • 2021$352.16M+71.6%
  • 2020$205.22M+13.0%
  • 2019$181.62M+6.6%
  • 2018$170.37M+18.8%
  • 2017$143.45M-0.3%
  • 2016$143.87M+3.2%
  • 2015$139.36M+1.9%
  • 2014$136.76M+10.7%
  • 2013$123.56M-2.5%
  • 2012$126.75M-0.4%
  • 2011$127.19M+14.3%
  • 2010$111.26M-0.1%
  • 2009$111.32M-3.5%
  • 2008$115.32M+27.4%
  • 2007$90.50M+5.7%
  • 2006$85.59M+15.0%
  • 2005$74.43M+13.5%
  • 2004$65.55M+21.2%
  • 2003$54.09M+95.5%
  • 2002$27.67M-40.3%
  • 2001$46.37M+19.7%
  • 2000$38.74M+36.4%
  • 1999$28.40M+39.9%
  • 1998$20.30M+62.4%
  • 1997$12.50M+27.6%
  • 1996$9.80M+34.2%
  • 1995$7.30M+15.9%
  • 1994$6.30M+40.0%
  • 1993$4.50M+15.4%
  • 1992$3.90M+116.7%
  • 1991$1.80M+63.6%
  • 1990$1.10M—

Operating Cash Flow values are taken from Bio-Techne's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Operating Cash Flow at Bio-Techne (TECH)

Operating Cash Flow for Bio-Techne (TECH): headline value $86.66M · YoY -3.8%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

In 2025, Bio-Techne (TECH) operating cash flow totalled $287.56M – edged down 3.8% year-over-year.

Over 2020–2025 (5 years), Bio-Techne operating cash flow expanded at a +7.0% compound annual rate, with mixed annual results across the window.

Bio-Techne operating cash flow peaked at $352.16M in 2021; the latest annual figure is $287.56M in 2025 (18.3% below peak).

The highest annual operating cash flow of $352.16M was reported in 2021. The lowest in the available history was $1.10M in 1990.

Bio-Techne Operating Cash Flow by Year

Bio-Techne Operating Cash Flow 2025: $287.56M

2025's operating cash flow for Bio-Techne came in at $287.56M, edged down 3.8% below 2024.

Bio-Techne Operating Cash Flow 2024: $298.98M

Bio-Techne posted operating cash flow of $298.98M in 2024, grew 17.5% from 2023.

Bio-Techne Operating Cash Flow 2023: $254.39M

In 2023, Bio-Techne reported operating cash flow of $254.39M, declined 21.8% below 2022.

Bio-Techne Operating Cash Flow 2022: $325.27M

Bio-Techne operating cash flow in 2022 was $325.27M, declined 7.6% below 2021.

Bio-Techne Operating Cash Flow 2021: $352.16M

Bio-Techne operating cash flow in 2021 was $352.16M.

See more financial history for Bio-Techne (TECH).

Sector peers by Operating Cash Flow

Healthcare peers of Bio-Techne (TECH), ranked by their latest operating cash flow

Frequently asked questions

Bio-Techne (TECH) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation